Evidence map›Paper›PMID 32290344›Full record

Trial reportNutrients2020

Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients.

William Chey, William Sandborn, Andrew J Ritter, Howard Foyt, M Andrea Azcarate-Peril, Dennis A Savaiano

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Two-week supplementation ofGut microbes reports · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

William CheyGastroenterology and Nutrition Sciences 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109, USA.
William SandbornDivision of Gastroenterology, University of California San Diego, San Diego, CA 92093, USA.
Andrew J RitterRitter Pharmaceuticals, Inc., Los Angeles, CA 90067, USA.
Howard FoytRitter Pharmaceuticals, Inc., Los Angeles, CA 90067, USA.
M Andrea Azcarate-PerilDepartment of Medicine, Division of Gastroenterology and Hepatology and UNC Microbiome Core, School of Medicine, University of North Carolina at Chapel Hill, NC 27514, USA.ORCID 0000-0003-0325-1289
Dennis A SavaianoMeredith Professor of Nutrition Science, Institution: Purdue University, West Lafayette, IN 47907, USA.ORCID 0000-0001-8872-6276

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAdolescentAdultAgedBifidobacteriumDairy ProductsDouble-Blind MethodEatingFecesFemaleGastrointestinal MicrobiomeHumansLactose IntoleranceMaleMiddle AgedOligosaccharidesOligosaccharidesRP-G28abdominal painbloatingdiarrheagalacto-oligosaccharidegasgut microbiomelactase non-persistencelactose intolerance

Identifiers

PMID32290344
PMCPMC7231374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.